Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy

被引:1
|
作者
Song, Young [1 ,2 ]
Bae, Myung Il [1 ,2 ]
Han, Dong Woo [1 ,2 ]
Park, Eun Jung [3 ]
Park, Sujung [1 ]
Ham, Sung Yeon [1 ,2 ]
机构
[1] Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, 211 Eonjuro, Seoul 06273, South Korea
[2] Yonsei Univ, Coll Med, Anesthesia & Pain Res Inst, Seoul, South Korea
[3] Yonsei Univ, Dept Surg, Coll Med, Div Colon & Rectal Surg, Seoul, South Korea
关键词
Bioelectrical impedance analysis; Hyperthermic intraperitoneal chemotherapy; Prognosis; BIOELECTRICAL-IMPEDANCE ANALYSIS; FAT-FREE BODY; ADIPOSE-TISSUE; CANCER-PATIENTS; PHASE-ANGLE; POSTOPERATIVE COMPLICATIONS; ELECTRICAL-IMPEDANCE; HYDRATION; SURVIVAL; MASS;
D O I
10.1186/s12957-023-03233-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Bioelectric impedance analysis (BIA)-measured body composition and nutritional status have been used as prognostic indicators in various cancer cohorts. This study investigated whether BIA could provide information on prognosis in peritoneal carcinomatosis patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).Methods We retrospectively analyzed the data of 99 patients with preoperative BIA data among those who underwent CRS and HIPEC. The association between BIA-derived parameters and intraoperative peritoneal cancer index (PCI) score was assessed. Predictive analysis for the occurrence of postoperative morbidities including major complications (Clavien-Dindo classification 3-4) and re-admission within 30 days after surgery as well as 1 year mortality was also performed.Results BIA-derived mineral (r = 0.224, p = 0.027), fat (r = - 0.202, p = 0.048), and total body water (TBW)/fat-free mass (FFM) (r = - 0.280, p = 0.005) showed significant associations with intraoperative PCI score. Lower TBW/FFM was an independent predictor of major postoperative complications (OR 0.047, 95% CI 0.003-0.749, p = 0.031) and re-admission (OR 0.094, 95% CI 0.014-0.657, p = 0.017) within 30 days after surgery. Higher fat mass was also independently associated with a higher risk of major postoperative complications (OR 1.120, 95% CI 1.006-1.248, p = 0.039) and re-admission (OR 1.123, 95% CI 1.024-1.230, p = 0.013). Intraoperative PCI score > 20 (OR 4.489, 95% CI 1.191-16.917, p = 0.027) and re-admission within 30 days after surgery (OR 5.269, 95% CI 1.288-21.547, p = 0.021) independently predicted postoperative 1-year mortality.Conclusions We demonstrate that preoperative BIA-derived TBW/FFM and fat mass were significantly correlated with metastatic extent, assessed by PCI score, in patients with peritoneal carcinomatosis. In addition, BIA-derived TBW/FFM and fat mass showed independent predictability for postoperative 30-day major complications and re-admission in patients undergoing CRS and HIPEC. Our findings suggest that assessment of BIA may improve discrete risk stratification in patients who are planned to receive CRS and HIPEC.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy
    Young Song
    Myung Il Bae
    Dong Woo Han
    Eun Jung Park
    Sujung Park
    Sung Yeon Ham
    [J]. World Journal of Surgical Oncology, 21
  • [2] The Role of Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in Recurrent Ovarian Peritoneal Carcinomatosis
    Ozcan, Pirilti
    Duzgun, Ozgul
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
  • [3] The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy
    Pomel, C
    Appleyard, TL
    Gouy, S
    Rouzier, R
    Elias, D
    [J]. EJSO, 2005, 31 (05): : 540 - 543
  • [4] Predicting incomplete cytoreduction and aborted hyperthermic intraperitoneal chemotherapy procedures in patients with peritoneal carcinomatosis
    Milovanov, V.
    Sardi, A.
    MacDonald, R.
    Gushchin, V.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S401 - S401
  • [5] Cytoreduction and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis dissemination from colorectal cancer
    Turner, Keli
    Alexander, H. Richard, Jr.
    [J]. COLORECTAL CANCER, 2012, 1 (02) : 125 - 135
  • [6] Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomixoma peritonei
    Cioppa, Tommaso
    Vaira, Marco
    Bing, Camilla
    D'Amico, Silvia
    Bruscino, Alessandro
    De Simone, Michele
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (44) : 6817 - 6823
  • [7] Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin
    Toshiyuki Kitai
    Kenya Yamanaka
    [J]. International Journal of Clinical Oncology, 2018, 23 : 298 - 304
  • [8] Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin
    Kitai, Toshiyuki
    Yamanaka, Kenya
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (02) : 298 - 304
  • [9] Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomixoma peritonei
    Tommaso Cioppa
    Marco Vaira
    Camilla Bing
    Silvia D’Amico
    Alessandro Bruscino
    Michele De Simone
    [J]. World Journal of Gastroenterology, 2008, 14 (44) : 6817 - 6823
  • [10] Impact of the Peritoneal Surface Disease Severity Score on Survival in Patients with Colorectal Cancer Peritoneal Carcinomatosis Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
    Terence C. Chua
    David L. Morris
    Jesus Esquivel
    [J]. Annals of Surgical Oncology, 2010, 17 : 1330 - 1336